Activation of muscle nicotinic acetylcholine receptor channels by nicotinic and muscarinic agonists

被引:46
|
作者
Akk, G [1 ]
Auerbach, A [1 ]
机构
[1] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA
关键词
nicotinic acetylcholine receptor; ion channel; agonist; acetylcholine; nicotine; carbamylcholine; oxotremorine; muscarine;
D O I
10.1038/sj.bjp.0702941
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The dose-response parameters of recombinant mouse adult neuromuscular acetylcholine receptor channels (nAChR) activated by carbamylcholine, nicotine, muscarine and oxotremorine were measured. Rate constants for agonist association and dissociation, and channel opening and closing, were estimated from single-channel kinetic analysis. 2 The dissociation equilibrium constants were (mM): ACh (0.16)<oxotremorine M (0.6)<carbamylcholine (0.8) <nicotine (2.6). 3 The gating equilibrium constants (opening/closing) were: ACh (45)> carbamylcholine (5.1)> oxotremorine M (0.6)>nicotine (0.5)>muscarine (0.15). 4 Rat neuronal alpha(4)beta(2) nAChR can be activated by all of the agonists. However, detailed kinetic analysis was impossible because the recordings lacked clusters representing the activity of a single receptor complex. Thus, the number of channels in the patch was unknown and the activation rate constants could not be determined. 5 Considering both receptor affinity and agonist efficacy, muscarine and oxotremorine are significant agonists of muscle-type nAChR. The results are discussed in terms of structure-function relationships at the nAChR transmitter binding site.
引用
收藏
页码:1467 / 1476
页数:10
相关论文
共 50 条
  • [1] Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
    Jones, Carrie K.
    Byun, Nellie
    Bubser, Michael
    [J]. NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 16 - 42
  • [2] Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
    Carrie K Jones
    Nellie Byun
    Michael Bubser
    [J]. Neuropsychopharmacology, 2012, 37 : 16 - 42
  • [3] Correlations in activation parameters of nicotinic acetylcholine receptor channels
    Zhou, M
    Auerbach, A
    [J]. BIOPHYSICAL JOURNAL, 2000, 78 (01) : 148A - 148A
  • [4] Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists
    Briggs, CA
    McKenna, DG
    [J]. NEUROPHARMACOLOGY, 1998, 37 (09) : 1095 - 1102
  • [5] Neuronal nicotinic acetylcholine receptor agonists
    McDonald, IA
    Vernier, JM
    Cosford, N
    CoreyNaeve, J
    [J]. CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (04) : 357 - 366
  • [6] Neuronal nicotinic acetylcholine receptor agonists
    Toma, L
    Barlocco, D
    Gelain, A
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) : 1029 - 1040
  • [7] Desensitization of diliganded mouse muscle nicotinic acetylcholine receptor channels
    Elenes, S
    Auerbach, A
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2002, 541 (02): : 367 - 383
  • [8] Activation of endplate nicotinic acetylcholine receptors by agonists
    Auerbach, Anthony
    [J]. BIOCHEMICAL PHARMACOLOGY, 2015, 97 (04) : 601 - 608
  • [9] Fluorescent agonists for the torpedo nicotinic acetylcholine receptor
    Krieger, Florian
    Mourot, Alexandre
    Araoz, Romulo
    Kotzyba-Hibert, Florence
    Molgo, Jordi
    Bamberg, Ernst
    Goeldner, Maurice
    [J]. CHEMBIOCHEM, 2008, 9 (07) : 1146 - 1153
  • [10] Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
    Verma, Stuti
    Kumar, Ashwini
    Tripathi, Timir
    Kumar, Awanish
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 70 (08) : 985 - 993